Skip to main content

Table 2 Drug susceptibility and minimum inhibitory concentration (µg/mL) of M. marseillense isolates

From: Tenosynovitis caused by Mycobacterium marseillense, initially identified as Mycobacterium avium complex using AccuProbe and COBAS TaqMan

No. SM EB KM RFP RBT LVFX MFLX CPFX CAM TH AMK LZD ST INH AZM Reference
1 R
>32
R
16
R
8
R
16
S
1
S
32
R
32
R
32/608
[6]
2 S R S S [7]
3 [8]
4 R R I S S S [9]
5 S S S S [10]
6 1 1 1 0.03 0.03 0.5 S
0.06
4 S
1
This Study
  1. SM, streptomycin; EB, ethambutol; KM, kanamycin; RFP, Rifampin; RBT, rifabutin; LVFX, levofloxacin; MFLX, moxifloxacin; CPFX, ciprofloxacin; CAM, clarithromycin; TH, ethionamide; AMK, amikacin; LZD, linezolid; ST, trimethoprim/sulfamethoxazole; INH, isoniazid; AZM, azithromycin. S, sensitive; I, intermediate; R, resistant. The drug susceptibility for case No.1- 5 are described as stated in the literatures [6,7,8,9,10]